Found 30 results
Filters: Keyword is Risk Assessment  [Clear All Filters]
Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, Andersen K E, Angers-Loustau A, Aptula A, Bal-Price A et al..  2011.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.. Arch Toxicol. 85(5):367-485.
Koster S, Boobis AR, Cubberley R, Hollnagel HM, Richling E, Wildemann T, Würtzen G, Galli CL.  2011.  Application of the TTC concept to unknown substances found in analysis of foods.. Food Chem Toxicol. 49(8):1643-60.
Del Rio Vilas VJ, Ancelet S, Abellan JJ, Birch CPD, Richardson S.  2011.  A Bayesian hierarchical analysis to compare classical and atypical scrapie surveillance data; Wales 2002-2006.. Prev Vet Med. 98(1):29-38.
Menvielle G, Kunst AE, van Gils CH, Peeters PH, Boshuizen H, Overvad K, Olsen A, Tjonneland A, Hermann S, Kaaks R et al..  2011.  The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition.. Am J Epidemiol. 173(1):26-37.
Boobis A, Budinsky R, Collie S, Crofton K, Embry M, Felter S, Hertzberg R, Kopp D, Mihlan G, Mumtaz M et al..  2011.  Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment.. Crit Rev Toxicol. 41(5):369-83.
Papathomas M, Molitor J, Richardson S, Riboli E, Vineis P.  2011.  Examining the joint effect of multiple risk factors using exposure risk profiles: lung cancer in nonsmokers.. Environ Health Perspect. 119(1):84-91.
Dorne J-LCM, Kass GEN, Bordajandi LR, Amzal B, Bertelsen U, Castoldi AF, Heppner C, Eskola M, Fabiansson S, Ferrari P et al..  2011.  Human risk assessment of heavy metals: principles and applications.. Met Ions Life Sci. 8:27-60.
Schüz J, Elliott P, Auvinen A, Kromhout H, Poulsen A H, Johansen C, Olsen JH, Hillert L, Feychting M, Fremling K et al..  2011.  An international prospective cohort study of mobile phone users and health (Cosmos): design considerations and enrolment.. Cancer Epidemiol. 35(1):37-43.
Park KB, Boobis A, Clarke S, Goldring CEP, Jones D, Kenna GJ, Lambert C, Laverty HG, Naisbitt DJ, Nelson S et al..  2011.  Managing the challenge of chemically reactive metabolites in drug development.. Nat Rev Drug Discov. 10(4):292-306.
Felter SP, Conolly RB, Bercu JP, Bolger MP, Boobis AR, Bos PMJ, Carthew P, Doerrer NG, Goodman JI, Harrouk WA et al..  2011.  A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.. Crit Rev Toxicol. 41(6):507-44.
de Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N et al..  2011.  Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults.. Am J Respir Crit Care Med. 183(7):891-7.
Carmichael N, Bausen M, Boobis AR, Cohen SM, Embry M, Fruijtier-Pölloth C, Greim H, Lewis R, Bette Meek ME, Mellor H et al..  2011.  Using mode of action information to improve regulatory decision-making: an ECETOC/ILSI RF/HESI workshop overview.. Crit Rev Toxicol. 41(3):175-86.